1. Paclitaxel-carboplatin combination chemotherapy in advanced breast cancer

   • G. Pentheroudakis
   • E. Razis
   • G. Fountzilas

   Review Pages: 147 - 160

2. Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors

   • Masahiro Tsuboi
   • Thierry Le Chevalier

   Review Pages: 161 - 170

3. Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer

   • Mónica Fernández-Sánchez
   • Armando Gamboa-Dominguez
   • Oscar Arrieta

   Original Article Pages: 171 - 183

4. Effect of concomitant use of pentoxifylline and alpha-tocopherol with radiotherapy on the clinical outcome of patients with stage IIIB non-small cell lung cancer

   • Cem H. Misirliogluo
   • Handan Erkal
   • Kadri Altundag

   Original Article Pages: 185 - 189

5. Recombinant adenoviruses expressing TRAIL demonstrate antitumor effects on non-small cell lung cancer (NSCLC)

   • F. Yang
   • P. Shi
   • M. Sun

   Original Article Pages: 191 - 204

6. Comparison of osteopontin expression in endometrioid endometrial cancer and ovarian endometrioid cancer

   • Yasunori Hashiguchi
   • Hiroshi Tsuda
   • Samuel C. Mok

   Original Article Pages: 205 - 212

7. The value of serum bcl-2 levels in advanced epithelial ovarian cancer

   • Faruk Tas
   • Derya Duranyildiz
   • Erkan Topuz

   Original Article Pages: 213 - 217

8. Pelvic exenteration for recurrent or persistent cervical cancer

   • M. A. Terán-Porcayo
   • I. Zeichner-Gancz
   • G. Solorza-Luna

   Original Article Pages: 219 - 223

9. Primary extranodal lymphomas of gastrointestinal localizations

   • B. Mihaljević
   • R. Nedeljkov-Jančić
   • N. Čolović

   Original Article Pages: 225 - 235

10. Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer

    • Wesam A. Nasif
    • Mahmoud Lotfy
    • Nabil Gad El-Hak

    Original Article Pages: 237 - 244

11. Modulation of human renal cell carcinoma 786-0 MMP-2 and MMP-9 activity by inhibitors and inducers in vitro

    • M. Waheed Roomi
    • Vadim Ivanov
    • Matthias Rath

    Original Article Pages: 245 - 250

12. Prophylactic tropisetron versus rescue tropisetron in fractionated radiotherapy to moderate or high emetogenic areas

    • K. Mystakidou
    • E. Katsouda
    • L. Vlahos

    Original Article Pages: 251 - 262

13. Efficacy and safety results with the combination therapy of arsenic trioxide, dexamethasone, and ascorbic acid in multiple myeloma patients

    • Rony M. Abou-Jawde
    • Janice Reed
    • Mohamad Hussein

    Original Article Pages: 263 - 272

14. Dendritic cells, pulsed with lysate of allogeneic tumor cells, are capable of stimulating MHC-restricted antigen-specific antitumor T cells

    • Reza Mahdian
    • Parviz Kokhaei
    • Håkan Mellstedt

    Original Article Pages: 273 - 282

15. Outcome for young high-risk aggressive B-cell lymphoma patients treated with CHOEP-14 and rituximab (R-CHOEP-14)

    • Magdalena Adde
    • Gunilla Enblad
    • Anna Laurell

    Original Article Pages: 283 - 293

16. Surgery and chemotherapy versus chemotherapy as treatment of high-grade MALT gastric lymphoma

    • Agustín Avilés
    • Natividad Neri
    • Sergio Cleto

    Original Article Pages: 295 - 300

17. Uterine choriocarcinoma in a postmenopausal woman

    • U. Mukherjee
    • V. Thakur
    • D. Pendharkar

    Case Reports Pages: 301 - 303